Stock USRM U.S. STEM CELL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Quotes U.S. Stem Cell, Inc.

Equities

USRM

US90350U1007

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 20:42:59 02/05/2024 BST 		5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for U.S. Stem Cell, Inc. 0.00% 0.00%
2023 U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2023 U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt CI

Quotes 5-day view

Delayed Quote OTC Markets
U.S. Stem Cell, Inc.(USRM) : Historical Chart (5-day)
  02/05/2024
Last 1.0E-6 $
Volume 102 475
Change +∞%
Opening 0.00
High 0.00
Low 0.00

Performance

1 day-99.00%

Volumes

markets
Daily volume
102 475
Estimated daily volume
120 208
Avg. Volume 20 sessions
187 732
Daily volume ratio
0.64
Avg. Volume 20 sessions USD
0.19
Record volume 1
92 449 550
Record volume 2
84 056 860
Record volume 3
71 136 990
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (USD)
661
Net sales (USD)
82 049
Number of employees
11
Sales / Employee (USD)
7 459
Free-Float
89.05 %
Free-Float capitalization (USD)
571
Average Daily Capital Traded
0.03%

Highs and lows

1 month
0.00
Extreme 0
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.04
5 years
0.00
Extreme 0
0.09
10 years
0.00
Extreme 0
37.90

Indicators

Moving average 50 days
0.00
Price spread / (MMA50)
+9,900.00%
RSI 9 days
44.03
RSI 14 days
44.64

Sector Comparison - Bio Therapeutic Drugs

Name Change 5d. change 1st Jan change 1-year change Capi.
U.S. STEM CELL, INC. Stock U.S. Stem Cell, Inc.
-99.00%0.00% - - 661
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+0.08%+4.90%+3.17%+21.73% 108B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.40%+3.40%+10.38%+28.43% 105B
ARGENX SE Stock argenx SE
-5.09%-3.91%+1.57%-3.99% 23.46B
BIONTECH SE Stock BioNTech SE
+1.89%-0.09%-12.68%-11.96% 21.72B
GENMAB A/S Stock Genmab A/S
-0.45%+1.91%-7.05%-27.08% 18.64B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
+1.48%+3.89%-37.64%-33.00% 17.45B
BEIGENE, LTD. Stock BeiGene, Ltd.
+1.71%+3.70%-6.85%-31.62% 17.19B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+0.63%+0.03%+6.16%+43.84% 13.99B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
-0.33%+1.90%+38.04%+6.18% 12.53B
VIKING THERAPEUTICS, INC. Stock Viking Therapeutics, Inc.
-0.24%+5.46%+329.34%+255.90% 8.81B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
+0.08%-0.11%-23.75%-32.40% 8.32B
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
+0.22%-5.13%+6.28%+37.72% 7.65B
CEREVEL THERAPEUTICS HOLDINGS, INC. Stock Cerevel Therapeutics Holdings, Inc.
+0.46%-1.08%-0.64%+28.33% 7.64B
WUXI BIOLOGICS (CAYMAN) INC. Stock WuXi Biologics (Cayman) Inc.
+3.26%+6.11%-50.74%-69.24% 7.52B
VAXCYTE, INC. Stock Vaxcyte, Inc.
-2.10%+1.71%+4.55%+23.16% 7.26B
Average-5.99%+2.13%+17.34%+15.73%
Weighted average by Cap.+0.38%+3.69%+8.44%+16.06%

Historical data

DateOpeningHighLowEnd-of-dayVolume

Chart U.S. Stem Cell, Inc.

Chart U.S. Stem Cell, Inc.
More charts

Monthly variations

Annual change

20240.00%
2023-99.98%
2022-20.00%
2021-50.82%
2020+248.57%
2019-78.13%
2018-44.83%
2017+1,387.18%
2016-99.78%
2015-91.67%
2014+5.00%
2013-33.33%
2012-66.52%
2011-86.42%
2010-55.41%
2009-25.25%
2008-80.20%
  1. Stock Market
  2. Equities
  3. USRM Stock
  4. Quotes U.S. Stem Cell, Inc.